05:48 PM EST, 11/05/2024 (MT Newswires) -- Mark W Hahn, Chief Financial Officer, on November 01, 2024, sold 129,672 shares in Verona Pharma ( VRNA ) for $568,387. Following the Form 4 filing with the SEC, Hahn has control over a total of 14,293,736 shares of the company, with 14,293,736 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1657312/000110465924114409/xslF345X05/tm2427415-1_4seq1.xml